Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)

China · Delayed Price · Currency is CNY

9.26

+0.84 (9.98%)

Aug 20, 2026, 3:04 PM CST

34.40% (1Y)

Market Cap	4.66B +36.6%
Revenue (ttm)	1.03B +1.3%
Net Income	225.27M +30.0%
EPS	0.45 +29.9%
Shares Out	503.20M
PE Ratio	20.69
Forward PE	n/a
Dividend	0.30 (3.56%)
Ex-Dividend Date	Jun 16, 2026

Volume	4,381,402
Open	7.28
Previous Close	8.42
Day's Range	7.28 - 9.26
52-Week Range	5.32 - 9.26
Beta	0.29
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2026

About SHE:002412

Hunan Hansen Pharmaceutical Co., Ltd. engages in the production and sale of traditional Chinese preparations in China and internationally. The company offers medications for digestive, cardiovascular, cerebrovascular, and urological diseases, as well as for traumatology and diagnostic applications. It provides its products in various forms, including injections, mixtures, tablets, capsules, granules, syrups, decoctions, tinctures, and pills. Hunan Hansen Pharmaceutical Co., Ltd. was founded in 1998 and is based in Yiyang, China. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1998

Employees 2,108

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002412

Full Company Profile

Financial Performance

In 2025, SHE:002412's revenue was 1.04 billion, an increase of 3.41% compared to the previous year's 1.00 billion. Earnings were 198.12 million, a decrease of -10.05%.

Financial Statements